GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 2,670.00
+2,136.00 (400.00%)
Jul 22, 2026, 7:45 AM KST
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 48.42 billion as of September 1, 2026. Its market cap has decreased by -77.97% in one year.
Market Cap
48.42B
Enterprise Value
76.85B
Revenue
12.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,670.00
ChartMarket Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 48.42B, an increase of 1,324.11%. That is a compound annual growth rate of 8.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 48.42B | -70.99% |
| Dec 30, 2025 | 166.91B | -1.14% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genexine | 120.29B |
| MedPacto | 95.46B |
| Vaxcell-Bio Therapeutics | 93.15B |
| iNtRON Biotechnology | 86.50B |
| Prestige BioPharma | 77.28B |
| Amicogen | 67.49B |
| ENCell | 65.29B |
| ORIENT BIO | 52.11B |